Mesenchymal Stromal Cells for Ischemic Stroke "SAMCIS"


Phase 1/2 Results N/A

Summary of Purpose

The purpose of this study is to determine if mesenchymal stem cells given by IV is feasible and safe in patients with recent ischemic stroke and to decide the maximum tolerated dose when given between 3-10 days after an ischemic stroke. Trial Stopped: Plan to change the trial design

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 April 2018.

1 Dec 2016 6 Aug 2013 1 Dec 2018 1 Dec 2018 1 Apr 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment